FDA Approves Butorphanol for Dog Pain and Cough Relief
Veterinarians now have a new tool to help manage pain and coughing in dogs. The FDA has approved butorphanol for use as a pain reliever and cough suppressant in canines. This opioid medication is relatively inexpensive, with a month's supply costing between $25 and $50.
Butorphanol is a versatile drug, typically used for sedation, anesthesia, antitussive effects, reversing mu-opioid agonist drugs, and mild analgesia. It works by stimulating kappa receptors for pain relief and blocking mu receptors to counteract other opioid drugs. The most common side effect is sedation, but it can also cause loss of appetite, nausea, diarrhea, and constipation.
Administration is straightforward. Butorphanol tablets should be given orally, either hidden in a treat or directly, following a vet's instructions. Outside the U.S., it's also approved as a cough suppressant to reduce coughing in dogs.
Butorphanol's approval expands veterinary options for managing pain and coughing in dogs. It's important to note that it can interact with other medications, particularly opioid drugs, tranquilizers, sedatives, and antidepressants. Always consult with a vet before administering butorphanol to ensure it's the right choice for your pet.
